GlassScriptPhysician profile
Grace A Montenegro
NPI 1497948087
$2,254.12
in general payments reported to CMS, 2019-2025
9 companies · $211 in 2025
The $211 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $803 · 2020: $201 · 2021: $48.11 · 2022: $287 · 2023: $692 · 2024: $11.16 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $514 · Food and Beverage: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $513.60 |
| Food and Beverage | $400.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $672.87 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Covidien LP | $400.00 | 2019 | |
| Conmed Corporation | $300.00 | 2019 | |
| Ethicon US, LLC | $269.59 | 2019-2022 | |
| Intuitive Surgical, INC. | $213.15 | 2021-2025 | |
| Medtronic, INC. | $144.07 | 2022-2025 | Eea, V-Loc 180 |
| Calyxo, INC. | $140.05 | 2025 | Cvac Aspiration System |
| Medical Device Business Services, INC. | $91.99 | 2019-2020 | |
| Solventum Corporation | $22.40 | 2025 | Prevena, V.A.C.Ulta, V.A.C. Veraflo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Montenegro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.